Demonstrating the Potential of Digital Biomarkers to Overcome Heterogeneity & Select Specific Schizophrenic Subpopulations
Time: 2:00 pm
day: Day One
Details:
- Introducing personalized treatment strategies in psychosis drug development by identifying patient subgroups based on digital biomarkers and clinical characteristics
- Reducing trial size and time by focusing on populations most likely to respond, enhancing drug efficacy, and minimizing adverse effects, especially in cases where traditional antipsychotics fail
